Prothena | PRTA - Nettoeinkommen

Aktienkurs
9.14
Täglich Wechseln
-0.38 -3.99%
Monatlich
-2.77%
Jährlich
-30.44%
Q1 Prognose
9.02




Nettoeinkommen Veränderung Datum
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
Akebia Therapeutics USD -12.24M 12.78M 2025-12
ALKERMES USD 49.34M 33.42M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Exelixis USD 193.58M 8.73M 2025-09
Immunic USD -24.37M 2.99M 2024-09
Incyte USD 299.28M 124.89M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
MacroGenics USD -14.16M 30.98M 2025-12
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Prothena USD -21.59M 14.95M 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Xoma USD -17.24M 33.23M 2024-09